Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer.

Kim MJ, Yeo SG, Kim ES, Min CK, Se An P.

Oncol Lett. 2013 Mar;5(3):840-844. Epub 2012 Dec 18.


A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer?

Sapkaroski D, Osborne C, Knight KA.

J Med Radiat Sci. 2015 Jun;62(2):142-51. doi: 10.1002/jmrs.108. Epub 2015 May 25. Review.


Hypofractionated radiotherapy for medically inoperable stage I non-small cell lung cancer.

Jiang W, Wang JY, Wang JB, Liang J, Hui ZG, Wang XZ, Zhou ZM, Wang LH.

Thorac Cancer. 2016 Apr 26;7(3):296-303. doi: 10.1111/1759-7714.12327. Epub 2015 Dec 16.


Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.

Haidar YM, Rahn DA 3rd, Nath S, Song W, Bazhenova L, Makani S, Fuster MM, Sandhu AP.

Ther Adv Respir Dis. 2014 Feb;8(1):3-12. doi: 10.1177/1753465813512545. Epub 2013 Dec 10.


Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer.

Manabe Y, Shibamoto Y, Baba F, Murata R, Yanagi T, Hashizume C, Iwata H, Kosaki K, Miyakawa A, Murai T, Yano M.

Pract Radiat Oncol. 2012 Oct-Dec;2(4):e137-43. doi: 10.1016/j.prro.2011.11.007. Epub 2011 Dec 29.


Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).

Navarria P, Ascolese AM, Mancosu P, Alongi F, Clerici E, Tozzi A, Iftode C, Reggiori G, Tomatis S, Infante M, Alloisio M, Testori A, Fogliata A, Cozzi L, Morenghi E, Scorsetti M.

Radiother Oncol. 2013 Jun;107(3):414-8. doi: 10.1016/j.radonc.2013.04.016. Epub 2013 May 28.


A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.

Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Belderbos J.

J Thorac Oncol. 2012 Sep;7(9):1382-93. doi: 10.1097/JTO.0b013e318260e00d.


Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.

Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):967-73. doi: 10.1016/j.ijrobp.2010.12.039. Epub 2011 Mar 4.


Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.

Davis JN, Medbery C, Sharma S, Pablo J, Kimsey F, Perry D, Muacevic A, Mahadevan A.

Radiat Oncol. 2015 May 15;10:113. doi: 10.1186/s13014-015-0417-5.


Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.

Lindberg K, Nyman J, Riesenfeld Källskog V, Hoyer M, Lund JÅ, Lax I, Wersäll P, Karlsson K, Friesland S, Lewensohn R.

Acta Oncol. 2015;54(8):1096-104. doi: 10.3109/0284186X.2015.1020966. Epub 2015 Mar 27.


[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.

Cancer Radiother. 2013 Jul-Aug;17(4):272-81. doi: 10.1016/j.canrad.2013.01.021. Epub 2013 May 24. French.


Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.

Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):344-9. doi: 10.1016/j.ijrobp.2009.05.004. Epub 2009 Sep 18.


Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751. Epub 2010 Jul 16.


A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.

Henderson MA, Hoopes DJ, Fletcher JW, Lin PF, Tann M, Yiannoutsos CT, Williams MD, Fakiris AJ, McGarry RC, Timmerman RD.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):789-95. doi: 10.1016/j.ijrobp.2009.02.051. Epub 2009 May 25.


Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.

Holt A, van Vliet-Vroegindeweij C, Mans A, Belderbos JS, Damen EM.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1560-7. doi: 10.1016/j.ijrobp.2010.09.014. Epub 2011 Feb 6.


Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.

Low JSh, Koh WY, Yap SP, Fong KW.

Ann Acad Med Singapore. 2007 Sep;36(9):778-83.


Feasibility of implementing stereotactic body radiation therapy using a non-commercial volumetric modulated arc therapy treatment planning system for early stage lung cancer.

Song Y, Mueller B, Obcemea C, Mychalczak B.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:409-12. doi: 10.1109/IEMBS.2011.6090130.


Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.

Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P.

Clin Lung Cancer. 2014 Jul;15(4):287-93. doi: 10.1016/j.cllc.2014.01.004. Epub 2014 Feb 4.


Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.

Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M.

Radiother Oncol. 2008 Apr;87(1):29-34. doi: 10.1016/j.radonc.2008.01.008. Epub 2008 Jan 30.


Supplemental Content

Support Center